| Pimozide |
Influence on apoptosis |
Western Blot |
5.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on apoptosis |
Western Blot |
10.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on apoptosis |
Western Blot |
20.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on apoptosis |
Western Blot |
5.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on apoptosis |
Western Blot |
10.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on apoptosis |
Western Blot |
20.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
5.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
10.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
20.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
5.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
10.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
20.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
5.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
10.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
20.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
5.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
10.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
20.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
5.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
10.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
20.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
5.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
10.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
20.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
5.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
10.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
20.00 µM |
Kit225 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
5.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
10.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on TRAIL/DR4 dependent apoptosis |
Flow cytometry- Annexin |
20.00 µM |
HuT102 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
2.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
2.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
Flow cytometry- Annexin |
1.00 µM |
peripheral blood mononuclear cells |
Homo sapiens (7 healthy patients) |
|
|
|
| Pimozide |
Influence on cell viability |
Flow cytometry- Annexin |
2.50 µM |
peripheral blood mononuclear cells |
Homo sapiens (7 healthy patients) |
|
|
|
| Pimozide |
Influence on cell viability |
Flow cytometry- Annexin |
5.00 µM |
peripheral blood mononuclear cells |
Homo sapiens (7 healthy patients) |
|
|
|
| Pimozide |
Influence on cell viability |
Flow cytometry- Annexin |
7.50 µM |
peripheral blood mononuclear cells |
Homo sapiens (7 healthy patients) |
|
|
|
| Pimozide |
Influence on cell viability |
Flow cytometry- Annexin |
10.00 µM |
peripheral blood mononuclear cells |
Homo sapiens (7 healthy patients) |
|
|
|
| Pimozide |
Influence on protein activity in patient tissue |
Western Blot |
20.00 µM |
lymphoma cells |
Homo sapiens (patient 112) |
|
p-STAT5 |
|
| Pimozide |
Influence on protein activity in patient tissue |
Western Blot |
20.00 µM |
lymphoma cells |
Homo sapiens (patient 112) |
|
STAT5 |
|
| Pimozide |
Influence on protein activity in patient tissue |
Western Blot |
20.00 µM |
lymphoma cells |
Homo sapiens (patient 112) |
|
|
|
| Pimozide |
Influence on apoptosis in patient tissue |
Flow cytometry- Annexin |
20.00 µM |
lymphoma cells |
Homo sapiens (patient 112) |
|
|
|
| Pimozide |
Influence on protein activity in patient tissue |
Western Blot |
20.00 µM |
lymphoma cells |
Homo sapiens (patient 706) |
|
p-STAT5 |
|
